Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01627808
Other study ID # 656/11
Secondary ID
Status Completed
Phase N/A
First received June 22, 2012
Last updated June 25, 2012
Start date September 2011
Est. completion date May 2012

Study information

Verified date June 2012
Source Catholic University of the Sacred Heart
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Observational

Clinical Trial Summary

The purpose of this study is to analyze hemodynamic changes, in patients undergoing liver resection, through the Vigileo/FloTrac system.


Description:

To reduce bleeding, hepatectomies are performed with low central pressure (CVP) combined with extrahepatic control flow.

This management can lead hemodynamic instability and reduction in oxygen delivery so an advanced monitoring should be used.

This study analyzes hemodynamic changes, in patients undergoing liver resection, through the Vigileo/FloTrac system.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date May 2012
Est. primary completion date February 2012
Accepts healthy volunteers No
Gender Both
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria:

- ASA I-III

Exclusion Criteria:

- Cirrhosis

- systolic ventricular contractility or diastolic relaxation alterations

- ischemic or valvular diseases

- absence of sinusal rhythm

- impaired renal function

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
Italy Catholic University of Sacred heart Rome

Sponsors (1)

Lead Sponsor Collaborator
Catholic University of the Sacred Heart

Country where clinical trial is conducted

Italy, 

References & Publications (8)

Bein B, Worthmann F, Tonner PH, Paris A, Steinfath M, Hedderich J, Scholz J. Comparison of esophageal Doppler, pulse contour analysis, and real-time pulmonary artery thermodilution for the continuous measurement of cardiac output. J Cardiothorac Vasc Anesth. 2004 Apr;18(2):185-9. — View Citation

Choukèr A, Schachtner T, Schauer R, Dugas M, Löhe F, Martignoni A, Pollwein B, Niklas M, Rau HG, Jauch KW, Peter K, Thiel M. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth. 2004 Aug;93(2):204-11. Epub 2004 Jun 11. — View Citation

Hickey R. How good is arterial pulse contour (LiDCO) and the esophageal Doppler monitor (HemoSonic) in measuring left ventricular stroke volume during venous occlusion? Crit Care Med. 2008 Nov;36(11):3103-4. doi: 10.1097/CCM.0b013e31818b927a. — View Citation

Marquez J, McCurry K, Severyn DA, Pinsky MR. Ability of pulse power, esophageal Doppler, and arterial pulse pressure to estimate rapid changes in stroke volume in humans. Crit Care Med. 2008 Nov;36(11):3001-7. doi: 10.1097/CCM.0b013e31818b31f0. — View Citation

Mayer J, Boldt J, Mengistu AM, Röhm KD, Suttner S. Goal-directed intraoperative therapy based on autocalibrated arterial pressure waveform analysis reduces hospital stay in high-risk surgical patients: a randomized, controlled trial. Crit Care. 2010;14(1):R18. doi: 10.1186/cc8875. Epub 2010 Feb 15. — View Citation

Smyrniotis V, Kostopanagiotou G, Theodoraki K, Tsantoulas D, Contis JC. The role of central venous pressure and type of vascular control in blood loss during major liver resections. Am J Surg. 2004 Mar;187(3):398-402. — View Citation

Stephenson KR, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH, Chang AE. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg. 1988 Dec;208(6):679-87. — View Citation

Torzilli G, Makuuchi M, Inoue K. The vascular control in liver resection: revisitation of a controversial issue. Hepatogastroenterology. 2002 Jan-Feb;49(43):28-31. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Stroke volume variation Evaluation of changes in Stroke Volume Variation from Vigileo/FloTrac system during liver resection. at time of surgery Yes
Secondary Stroke volume variation Evaluation of changes in Stroke Volume Variation at the end of liver resection, during fluid optimization. at the end of surgery Yes
See also
  Status Clinical Trial Phase
Withdrawn NCT05109052 - Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma Phase 1/Phase 2
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Completed NCT05030090 - Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer N/A
Terminated NCT00669136 - Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma Phase 1
Not yet recruiting NCT05041335 - Wet Heparinized Suction for Abdominal Cancer N/A
Recruiting NCT04258813 - Onco-primary Care Networking to Support TEAM-based Care N/A
Completed NCT03299036 - Drug-loadable(T-ACE Beads)for Hepatoma Embolization Therapy N/A
Recruiting NCT03323996 - Impact of a Training in Therapeutic Education on the Relation Between Care Givers and Their Patients N/A
Completed NCT02044224 - Effects of Dexmedetomidine During IRE Procedures for Solid Tumours Phase 4
Not yet recruiting NCT03607643 - A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Phase 1/Phase 2
Completed NCT05643833 - Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Not yet recruiting NCT03766776 - Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC) N/A
Completed NCT02016391 - Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours Phase 4
Recruiting NCT00730860 - Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE N/A
Terminated NCT00216437 - Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma Phase 1
Completed NCT04172714 - Low-dose Y90 Treatment Planning for HCC N/A
Active, not recruiting NCT03347162 - Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer
Completed NCT05907772 - Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma